Morgans Blog | Morgans

2020 Click here to expand or collapse the 2020 posts
2019 Click here to expand or collapse the 2019 posts
2018 Click here to expand or collapse the 2018 posts
- December (14) Click here to expand or collapse this months posts
- November (32) Click here to expand or collapse this months posts

Podcast: Morgans Conversation - Ron Weinberger, CEO of EMvision (ASX:EMV)

11 June 2020, 8:23 AM

I chat with Dr Ron Weinberger, Chief Executive Officer for EMVision (ASX: EMV) about the progress the company is making with their medical imaging technology to assist with stroke diagnosis.

Podcast: Healthcare sector update

By Scott Power

12 May 2020, 12:45 PM

I outline our preferred healthcare exposures, discuss Cochlear’s recent trading update and flag telehealth as a structural shift occurring in the industry.

Sonic Healthcare: COVID-19 Patients running scared

By Derek Jellinek

24 April 2020, 4:30 PM

Lab testing volumes appear to be rapidly declining as elective procedures are curtailed and patients put off even routine doctor's visits on the fear of COVID-19.

Under The Microscope: Company Updates - Scott Power, Senior Analyst

By Scott Power

21 April 2020, 9:05 AM

Morgans Senior Analyst Scott Power updates the network with information on 3 companies: Volpara (ASX:VHT), Impedimed (ASX:IPD) and Micro-X (ASX:MX1).

ResMed Inc: 1Q beats – strong and balanced

By Derek Jellinek

28 October 2019, 11:25 AM

First quarter showed strength across the board, with market beating growth in sleep and respiratory care, underpinned by flow generator connected device solutions and exceptional growth on the back of multiple new mask launches.